News & Updates

Show Multimedia Only

Hormone therapy effect on BP dictated by estrogen type

09 May 2024

In postmenopausal women, hormone therapy (HT) affects blood pressure (BP) differently based on the formulations used, especially the type of estrogen, according to a study.

Hormone therapy effect on BP dictated by estrogen type

09 May 2024

Rapid, durable responses with nab-sirolimus in gynaecologic or peritoneal PEComa

09 May 2024 by

Treatment with the mammalian target of rapamycin inhibitor nab-sirolimus yields rapid and durable responses among patients with perivascular epithelioid sarcoma (PEComa) of gynaecologic or peritoneal origin in a subgroup analysis of the phase II AMPECT trial.

Rapid, durable responses with nab-sirolimus in gynaecologic or peritoneal PEComa

09 May 2024

Full-bladder strategy enhances endometrial sampling experience

08 May 2024

Pipelle endometrial sampling with a full bladder reduces initial insertion failure rate and procedure-related pain, thereby increasing patient satisfaction, as compared with the standard process, according to a study.

Full-bladder strategy enhances endometrial sampling experience

08 May 2024

MIRASOL PRO data boost mirvetuximab soravtansine potential in FRα-positive ovarian cancer

06 May 2024 by

Patient-reported outcomes (PROs) from the phase III MIRASOL trial underpin the potential of the antibody drug conjugate mirvetuximab soravtansine (MIRV) to improve health-related quality of life (HRQoL) in women with folate receptor-alpha positive platinum-resistant ovarian cancer (FRα-positive PROC) as opposed to investigator’s choice of chemotherapy.

MIRASOL PRO data boost mirvetuximab soravtansine potential in FRα-positive ovarian cancer

06 May 2024

Dostarlimab-chemo a new SoC for endometrial cancer?

02 May 2024 by

In the second interim analysis of part 1 of the phase III ENGOT-EN6-NSGO/GOG-3031/RUBY trial, dostarlimab plus carboplatin/paclitaxel (CP) chemotherapy delivered a significant survival benefit in women with primary advanced or recurrent endometrial cancer.

Dostarlimab-chemo a new SoC for endometrial cancer?

02 May 2024

Medroxyprogesterone acetate a viable option for preventing ovulation during IVF

02 May 2024

In women undergoing autologous in vitro fertilization (IVF) for fertility treatment, ovulatory suppression with medroxyprogesterone acetate proves effective, with cycle and reproductive outcomes similar to that with gonadotropin-releasing hormone (GnRH) antagonist and the advantage of being cheaper, according to a study.

Medroxyprogesterone acetate a viable option for preventing ovulation during IVF

02 May 2024

Oral lasofoxifene helps improve genitourinary syndrome of menopause

01 May 2024

Oral lasofoxifene at either 0.25 or 0.5 mg daily confers benefits on genitourinary syndrome of menopause, with pooled data from two phase III trials showing significant improvements in vaginal signs or symptoms while having a favourable safety profile.

Oral lasofoxifene helps improve genitourinary syndrome of menopause

01 May 2024

Improved cervical screening uptake among local South Asian women following CUHK training

01 May 2024 by

Expansion of a territory-wide cervical screening programme to train a group of local South Asian women has enabled education regarding cervical cancer and screening services among their peers, and considerably improved screening uptake.

Improved cervical screening uptake among local South Asian women following CUHK training

01 May 2024

Antenatal corticosteroid exposure poses no major threat to infant neurodevelopment

30 Apr 2024

Children who were exposed antenatally to betamethasone as opposed to placebo are not necessarily at a disadvantage in terms of neurodevelopment outcomes, as shown in a follow-up to the Antenatal Late Preterm Steroids (ALPS) trial.

Antenatal corticosteroid exposure poses no major threat to infant neurodevelopment

30 Apr 2024

Maternal fish oil supplementation tied to overweight in children

27 Apr 2024 by

Children of mothers who took n‒3 long-chain polyunsaturated fatty acid (LCPUFA) supplements during pregnancy tend to have an increased body mass index (BMI) at age 10 years, a higher risk of being overweight, and greater fat percentage and metabolic syndrome score, a study has shown.

Maternal fish oil supplementation tied to overweight in children

27 Apr 2024

News & Updates

Filter by Specialty:

Specialty:

Hormone therapy effect on BP dictated by estrogen type

Hormone therapy effect on BP dictated by estrogen type

Rapid, durable responses with nab-sirolimus in gynaecologic or peritoneal PEComa

Rapid, durable responses with nab-sirolimus in gynaecologic or peritoneal PEComa

Full-bladder strategy enhances endometrial sampling experience

Full-bladder strategy enhances endometrial sampling experience

MIRASOL PRO data boost mirvetuximab soravtansine potential in FRα-positive ovarian cancer

MIRASOL PRO data boost mirvetuximab soravtansine potential in FRα-positive ovarian cancer

Dostarlimab-chemo a new SoC for endometrial cancer?

Dostarlimab-chemo a new SoC for endometrial cancer?

Medroxyprogesterone acetate a viable option for preventing ovulation during IVF

Medroxyprogesterone acetate a viable option for preventing ovulation during IVF

Oral lasofoxifene helps improve genitourinary syndrome of menopause

Oral lasofoxifene helps improve genitourinary syndrome of menopause

Improved cervical screening uptake among local South Asian women following CUHK training

Improved cervical screening uptake among local South Asian women following CUHK training

Antenatal corticosteroid exposure poses no major threat to infant neurodevelopment

Antenatal corticosteroid exposure poses no major threat to infant neurodevelopment

Maternal fish oil supplementation tied to overweight in children

Maternal fish oil supplementation tied to overweight in children